Novolin N Injection FlexPen, manufactured by Novo Nordisk Pharma, contains insulin human (recombinant). This intermediate-acting insulin suspension is used to improve glycemic control in adults and pediatric patients with diabetes mellitus. It has a YJ code of 2492413G1059 and a standard of 300 units per kit.
Novolin N Injection FlexPen
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →